Journal: Scientific reports
Article Title: Repeated 5-aminolevulinic acid mediated sonodynamic therapy using magnetic resonance guided focused ultrasound in rat brain tumour models.
doi: 10.1038/s41598-025-85314-6
Figure Lengend Snippet: Fig. 4. (A) We further investigate the efficiency of SDT in the human glioblastoma U87 rat model. The animal received three weekly treatments beginning from day 7. (B) The representative T1 contrast-enhanced MR images of control, FUS alone, 5-ALA alone, and SDT treatment. The first row in the SDT group demonstrated the long-term tumour-free survivor. The tumour disappeared after three treatments. However, SDT had a minimal impact on some animals, such as the second row in the SDT group. (C) The H&E stains stood for the animals from (B), respectively. (D) A significant difference was found in the third week between the control group and the SDT group. (E) The log-rank test showed prolonged survival in the SDT group, p = 0.01. (F) The body weight in all groups did not vary during three-week treatments.
Article Snippet: Rodent 9L gliosarcoma and human U87 MG glioma brain tumour cells Rodent 9L gliosarcoma brain tumour cells (ATCC® CRL-2200TM) and human U87 MG glioblastoma (ATCC® HTB14TM) purchased from ATCC were cultured respectively in DMEM (Dulbecco’s modified Eagle’s medium) and EMEM (Eagle’s Minimum Essential Medium) and supplemented with 10% heat-inactivated fetal bovine serum (FBS) in 75 cm2 flasks in a 5% CO2-containing incubator at 37 °C.
Techniques: Control